Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc
- PMID: 3744552
- PMCID: PMC260829
- DOI: 10.1128/iai.53.3.573-581.1986
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc
Abstract
This study was undertaken to determine whether a binding site for Clostridium difficile enterotoxin (toxin A) exists in the brush border membranes (BBMs) of the hamster, an animal known to be extremely sensitive to the action of the toxin. Toxin A was the only antigen adsorbed by the BBMs from the culture filtrate of C. difficile. The finding that binding activity could not be destroyed by heat indicated that a carbohydrate moiety might be involved. We therefore examined erythrocytes from various animal species for binding activity since erythrocytes provide a variety of carbohydrate sequences on their cell surfaces. Only rabbit erythrocytes bound the toxin, and the cells agglutinated. A binding assay based on an enzyme-linked immunosorbent assay method for quantifying C. difficile toxin A was used to compare binding of the toxin to hamster BBMs, rabbit erythrocytes, and BBMs from rats, which are less susceptible to the action of C. difficile toxin A than hamsters. Results of this comparison indicated the following order of toxin-binding frequency: rabbit erythrocytes greater than hamster BBMs greater than rat BBMs. Binding of toxin A to hamster BBMs at 37 degrees C was comparable to what has been observed with cholera toxin, but binding was enhanced at 4 degrees C. A similar binding phenomenon was observed with rabbit erythrocytes. Examination of the cell surfaces of hamster BBMs and rabbit erythrocytes with lectins and specific glycosidases revealed a high concentration of terminal alpha-linked galactose. Treatment of both membrane types with alpha-galactosidase destroyed the binding activity. The glycoprotein, calf thyroglobulin, also bound the toxin and inhibited toxin binding to cells. Toxin A did not bind to human erythrocytes from blood group A, B, or O donors. However, after fucosidase treatment of human erythrocytes, only blood group B erythrocytes, which possess the blood group B structure Gal alpha 1-3[Fuc alpha 1-2]Gal beta 1-4GlcNAc-R, bound the toxin. This indicated that toxin A was likely binding to Gal alpha 1-3Gal beta 1-4GlcNAc, a carbohydrate sequence also found on calf thyroglobulin and rabbit erythrocytes. All of the results indicate that hamster BBMs contain a carbohydrate-binding site for toxin A that has at least a Gal alpha 1-3Gal beta 1-4GlcNAc nonreducing terminal sequence.
Similar articles
-
Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences.Arch Biochem Biophys. 1987 Aug 15;257(1):217-29. doi: 10.1016/0003-9861(87)90561-3. Arch Biochem Biophys. 1987. PMID: 3115180
-
Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.Glycobiology. 1996 Sep;6(6):599-609. doi: 10.1093/glycob/6.6.599. Glycobiology. 1996. PMID: 8922955
-
Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters.Infect Immun. 1991 Apr;59(4):1223-30. doi: 10.1128/iai.59.4.1223-1230.1991. Infect Immun. 1991. PMID: 1900806 Free PMC article.
-
Purification of a functional receptor for Clostridium difficile toxin A from intestinal brush border membranes of infant hamsters.Clin Infect Dis. 1993 Jun;16 Suppl 4:S219-27. doi: 10.1093/clinids/16.supplement_4.s219. Clin Infect Dis. 1993. PMID: 8324123
-
Differential binding properties of Ga1NAc and/or Ga1 specific lectins.Adv Exp Med Biol. 1988;228:205-63. Adv Exp Med Biol. 1988. PMID: 3051916 Review.
Cited by
-
Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.Toxins (Basel). 2016 May 3;8(5):134. doi: 10.3390/toxins8050134. Toxins (Basel). 2016. PMID: 27153087 Free PMC article. Review.
-
Controversies Surrounding Clostridium difficile Infection in Infants and Young Children.Children (Basel). 2014 Jun 13;1(1):40-7. doi: 10.3390/children1010040. Children (Basel). 2014. PMID: 27417466 Free PMC article. Review.
-
Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.J Clin Invest. 1988 Jun;81(6):1741-5. doi: 10.1172/JCI113514. J Clin Invest. 1988. PMID: 2838520 Free PMC article.
-
New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.Infect Immun. 2000 Mar;68(3):1094-101. doi: 10.1128/IAI.68.3.1094-1101.2000. Infect Immun. 2000. PMID: 10678912 Free PMC article.
-
Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.J Biol Chem. 2014 Jun 27;289(26):18008-21. doi: 10.1074/jbc.M114.560748. Epub 2014 May 12. J Biol Chem. 2014. PMID: 24821719 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources